Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Status:
Recruiting
Trial end date:
2026-01-13
Target enrollment:
Participant gender:
Summary
This research study is designed to provide a better understanding of study drugs cetuximab
(Erbitux®) and palbociclib when used in combination to treat patients with metastatic colon
cancer.